This is a federal contract award from the National Cancer Institute, a civilian agency, to Robin Medical Inc., a for-profit small business organization. The contract has a value ceiling of $250,000.00 and is a definitive, firm fixed-price contract. The contract was awarded on September 30, 2010 with an ultimate completion date of October 31, 2011. The contract has a "Total Small Business" set-aside designation. The contract is for services described as "TAS::75 0849::TAS",...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency, to Biosono Inc., a minority-owned for-profit business. The contract is for the development of a biosensor-based core needle tumor biopsy device, under SBIR Topic 331. The fixed-price contract has a ceiling value of $224,961 and a completion date of September 11, 2015. As an SBIR Phase I contract, this represents early-stage research and development work to potentially...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This is a $1,988,212.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI) to Broad Axe Care Coordination LLC, doing business as Locus Health. The contract is for the MOONSHOT SBIR TOPIC 406 project, titled "CANCER NAVIGATION PLATFORM", and has a period of performance through December 18, 2024. The contract is a Firm Fixed Price Definitive Contract. This SBIR award is part of the NCI's MOONSHOT SBIR program, which focuses on...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $224,990 Firm Fixed Price contract is for the development of a photoacoustic needle for identifying tumor content, under SBIR Topic 331. Actuated Medical, a woman-owned small business manufacturer of medical devices, is conducting this...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Woodtoga Holdings Company, a for-profit manufacturer, for the development of "Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy." The $399,779.00 firm fixed price contract runs through December 31, 2022 and is set aside for small businesses. This contract supports the SBIR program...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Healthmyne, Inc., a for-profit small business organization. The contract, valued at $225,000.00, is a definitive firm fixed-price contract related to the "QIDS: USING RADIOMICS TO IMPACT RADIOTHERAPY TREATMENT PLANNING - MOONSHOT" effort, which was originally solicited under the National Institutes of Health and Centers for Disease Control and...
<p>The National Cancer Institute (NCI) awarded a $249,792 Small Business Innovation Research (SBIR) Phase I contract to Biotex, Inc. to develop "Instruments and Devices that Preserve Molecular Profiles in Tumors" under SBIR Topic 257. The contract is a firm-fixed-price definitive contract with a period of performance ending on June 30, 2010. This SBIR contract supports the NCI's research objectives related to advancing cancer diagnostics and therapeutics.</p>
This is a $224,987 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract is for the "POST-TREATMENT HEALTH OUTCOMES OF CANCER SURVIVORSHIP (POSTHOC)- MOONSHOT" research project, which is part of the Small Business Innovation Research (SBIR) program, a Phase I...